Sono Motors to Produce Sion in Sweden / First series production SEV to be manufactured at former SAAB plant in Trollhättan
more
Stories about Neue Produkte
- 2
HARTING presents intelligent connectivity at HANNOVER MESSE for the next steps towards the Future Factory (FOTO)
more Sono Motors Presents Design of the Sion / Innovative electric car features full-surface solar integration and more space
more- 2
Sedus reinvents the swivel chair - two world premieres at Orgatec 2018 (FOTO)
more Magnic Innovations GmbH & Co KG
11Magnic Light's new EUR 1 million Kickstarter campaign introduces revolutionary all-in-1 cycling lights
moreYanfeng Automotive Interiors develops innovative overhead console / Slim overhead console improves comfort and spaciousness
more
Volvo Cars Takes Luxury to a New Level Unveiling Lounge Console in Shanghai
Gothenburg, Sweden (ots/PRNewswire) - Volvo Cars has unveiled a new concept that takes executive in-car luxury to a new level at the Shanghai Motor Show. Labelled the Lounge Console, the concept offers busy chauffeur-driven business people the ultimate executive accessory; a compact and versatile solution to expanded storage and comfort. The Lounge Console replaces the ...
morePresident of EU Parliament Martin Schulz: "Europe is not keeping its promise"
Berlin (ots) - In an interview for the launch of the Axel Springer Akademie's English-language digital magazine "GENERATION SEPARATION", the President of the European Parliament, Martin Schulz (SPD), voiced strong criticism of European politics and its representatives. More and more young people perceive Europe as "undemocratic , boring and aloof." Schulz verbatim: ...
moreAudi takes to the race track with the sportiest piloted driving car in the world
Ingolstadt/Hockenheim (ots) - Audi has developed the world?s sportiest piloted driving car. At the German Touring Car Masters (DTM) season finale, the Audi RS 7 piloted driving concept car will demonstrate its dynamic potential and driving capabilities for the first time on the Hockenheimring - at racing speed, without a driver. "We are pressing forward with one of the ...
moreVolvo Cars Adds Android Auto to its Next Generation Cars
Göteborg, Sweden (ots/PRNewswire) - Volvo Car Group joins the Open Automotive Alliance Volvo Car Group (Volvo Cars) has joined the Open Automotive Alliance to make the Android smartphone platform available to drivers through its new ground-breaking user interface. This move brings together one of the world's most progressive car companies and the world's most popular smartphone platform, developed by Google. To view the ...
moreVolvo and Apple Forge Global Alliance
Gothenburg, Sweden (ots/PRNewswire) - Volvo Car Group and Apple Inc. are joining forces to make Apple's widely-used and hugely admired operating system available to drivers, bringing together one of the world's most progressive car companies and the world's most famous technology company. To view the Multimedia News Release, please click: http://www.multivu.com/mnr/65022-volvo-and-apple-forge-global-alliance The alliance ...
moreVolvo Reveals New Design Direction as Part of Brand Transformation
Gothenburg (ots/PRNewswire) - Volvo Car Group reveals the Concept Coupe, the first of three concept cars launched over a seven month period which will outline the future design direction of the Swedish car brand. The unveil of the new design vision marks a key moment in the rapid transformation of Volvo where the new design language will focus on injecting more emotion into the brand. The culmination of the three concept ...
more
Volvo Cars' New Drive-E Powertrains - Efficient Driving Pleasure with World-first Technologies
Gothenburg, Sweden (ots/PRNewswire) - Volvo Cars' new Drive-E range of powertrains takes efficient driving pleasure to a new dimension in which the number of cylinders is no longer important to describe power and drivability. To view the Multimedia News Release, please click: ...
moreHigh-end sports machine - the Audi e-bike Wörthersee
Reifnitz/Ingolstadt (ots) - - Like in motor racing: fully focused on peak performance - Frame, swinging arm and wheels made of carbon in line with the Audi ultra lightweight design principle - Head of Design Wolfgang Egger: "Stringent functionality and extreme sportiness as the foremost principles for the design." Starting May 16, ...
moreTwo Opel World Premieres at the 2012 Geneva Show
Rüsselsheim (ots) - - Mokka sub-compact SUV and Astra OPC to debut in Geneva - Opel unveils "RAD e" - first e-bike built around automotive construction principles - Ampera among finalists of "Car of the Year 2012" award - Opel press conference on March 6, 11:30 hrs in Hall 2 Opel is looking forward to two world premieres at this year's Geneva Motor Show (March 6-18, 2012): the all-new Mokka sub- compact SUV and the new ...
moreBoehringer Ingelheim Receives Approval From the European Commission for Mirapexin(R)/Sifrol(R) Prolonged-Release, Once Daily Tablet for the Treatment of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - New Formulation Brings the Established Efficacy of Mirapexin(R)/Sifrol(R) to Patients With Parkinson's Disease in the Convenience of a Once Daily Dose Boehringer Ingelheim today announced that the Mirapexin(R)/Sifrol(R) (pramipexole) new prolonged-release , once daily tablet ...
moreVodafone is exhibiting at the IFA again in September 2009 / Innovative communication and entertainment products and services on an area of over 1000 sq. m.
Düsseldorf/Berlin (ots) - Tomorrow it will be time for the IFA, the world's biggest trade fair for consumer electronics, to open its doors again in Berlin. Vodafone is exhibiting at this year's fair for the first time as integrated communications service provider. The IFA takes place from 4 to 9 September 2009 and ...
moreExperts Unite to Create New Online Resource for Restless Legs Syndrome
Ingelheim, Germany (ots/PRNewswire) - - Unique Educational Website 'Under the Covers of Restless Legs Syndrome (RLS)' is Launched on World Sleep Day - For Non-US Healthcare Media The website http://www.rlsunderthecovers.com brings together leading medical experts in the field of Restless Legs Syndrome (RLS) who have undertaken to explain key facts and symptoms of this ...
more
MICARDIS(R)- Based Regimens Help More Patients Achieve Their Blood Pressure Goals
Berlin (ots/PRNewswire) - - For non-US Healthcare Media and non-UK Healthcare Media - New Studies Show Benefits of MICARDIS(R) (Telmisartan) in Combination With Amlodipine and Hydrochlorothiazide The results of two new studies of MICARDIS(R) (telmisartan) in free combination with amlodipine or fixed combination with hydrochlorothiazide (HCTZ) 25 mg confirm that a ...
moreNew Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It ...
moreBoehringer Ingelheim to Initiate First Phase III Pivotal Study for New Oncology Compound BIBW 2992(i)
Ingelheim, Germany (ots/PRNewswire) - - New Data on BIBW 2992(i), a Potent, Irreversible, Second-Generation Oral Signal Transduction Inhibitor Provides Glimpse of Next Chapter in Lung Cancer Care - For Non-US Media Boehringer Ingelheim announced today from the 12th World Conference on Lung Cancer (WCLC) that the company plans to commence Phase III ...
moreEfficacy of Boehringer Ingelheim's Pramipexole (Mirapexin(R)/Sifrol(R) Also Demonstrated in Patients With Daytime RLS Symptoms
Ingelheim Am Rhein, Germany (ots/PRNewswire) - - Studies Reinforce the Benefits of Pramipexole From Daytime Symptom Control, Including Afternoon and Early Evening Onset - For Healthcare Media Outside the U.S.A. New data demonstrate that pramipexole (Mirapexin(R)/Sifrol(R)) is also efficacious and ...
moreBoehringer Ingelheim Receives Recommendation From EU Scientific Committee for Sifrol(R)/ Mirapexin(R) (Pramipexole) for the Treatment of Restless Legs Syndrome (RLS)
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Professional Media Boehringer Ingelheim announced today that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Sifrol(R) / Mirapexin(R) ...
moreNew Data Confirm Pramipexole Delivers Sustained Efficacy For Patients With Restless Legs Syndrome
Berlin, Germany (ots/PRNewswire) - - For Healthcare Professional Journalists - Not for distribution to US media - Randomised, Placebo-Controlled Study Shows Discontinuation of Pramipexole Leads to Rapid Worsening of Symptoms - Two new, randomised, placebo-controlled studies presented this week at the ...
more
Positive Opinion in Europe for Tipranavir
Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...
moreeuro adhoc: MediGene AG / MediGene's First Drug Eligard® Is Launched (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried - San Diego, May 4, 2004. Eligard®, the first drug of the German-American biotechnology company MediGene AG (Frankfurt, Prime Standard: MDG), is available in German pharmacies today. With the launch of the prescription drug to treat ...
moreeuro adhoc: MediGene AG / MediGene Achieves Excellent Clinical Results With Polyphenon® E Ointment in European Phase 3 Trial (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried - San Diego, March 31, 2004. The German-American biotech company MediGene AG (Frankfurt, Prime Standard: MDG) has achieved excellent results in a European phase 3 trial of the ...
more
Previous123